HLA-A and neoplasm: On the other hand, HLA-A*24:02-restricted CD8+ T cell antitumor immune responses have been detected in PCa [38,40], in many cases being much stronger than those restricted by HLA-A*02:01, making it unlikely that immune selection of tumor cell escape variants could be the predominant mechanism for HLA-A genotype-related disease prognosis.